BioNxt Solutions Inc. (CVE:BNXT) | WebDisclosure

Basculer en Français

10604	Companies
225013	Keywords
153734	Articles
119072	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

BRIEF

published on 06/15/2026 at 09:50, 5 days 17 hours ago

BioNxt accélère la commercialisation de son traitement breveté contre la sclérose en plaques

Sclérose En Plaques Développement Commercial Cladribine Solutions BioNxt BNT23001
BRIEF

published on 06/15/2026 at 09:50, 5 days 17 hours ago

BioNxt Advances Commercialization for Patented Multiple Sclerosis Treatment

Business Development Multiple Sclerosis Cladribine BioNxt Solutions BNT23001
PRESS RELEASE

published on 06/15/2026 at 09:45, 5 days 17 hours ago

BioNxt Engages Business Development & Licensing Advisors for Commercialization of Patented Sublingual Cladribine ODF
BioNxt Solutions Inc. partners with a BD&L advisor to commercialize BNT23001, a sublingual Cladribine ODF for MS. Preparing for a human bioavailability study

BioNxt Solutions Inc. Commercialization BNT23001 Bioavailability Study BD&L Advisor
BRIEF

published on 06/12/2026 at 23:20, 8 days 4 hours ago

BioNxt Solutions Inc. Announces Private Placement Initiative

Private Placement Stock Warrants BioNxt Solutions R&D Funding European Operations
BRIEF

published on 06/12/2026 at 23:20, 8 days 4 hours ago

BioNxt Solutions Inc. annonce une initiative de placement privé

Placement Privé Bons De Souscription D'actions Solutions BioNxt Opérations Européennes FINANCEMENT DE LA R&D
PRESS RELEASE

published on 06/12/2026 at 23:15, 8 days 4 hours ago

BioNxt Announces Non-Brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
BioNxt Solutions Inc. announces non-brokered private placement of units at $0.33 per Unit with maximum gross proceeds of $2,000,000. Offering includes common shares and purchase warrants

Private Placement Common Shares BioNxt Solutions Inc. LIFE Offering Purchase Warrants
BRIEF

published on 06/11/2026 at 00:35, 10 days 2 hours ago

BioNxt Solutions Inc. prolonge l'émission d'obligations convertibles et émet des bons de souscription.

Obligations Convertibles Législation Sur Les Valeurs Mobilières Mandats Approbation Réglementaire Solutions BioNxt
BRIEF

published on 06/11/2026 at 00:35, 10 days 2 hours ago

BioNxt Solutions Inc. Extends Convertible Debentures and Issues Warrants

Warrants Convertible Debentures Regulatory Approval Securities Legislation BioNxt Solutions
PRESS RELEASE

published on 06/11/2026 at 00:30, 10 days 2 hours ago

BioNxt Solutions Inc. Announces Extension of Convertible Debentures and Issuance of Warrants
BioNxt Solutions Inc. announces amendment of terms for unsecured convertible debentures, extending maturity dates and issuing common share purchase warrants. For further details, visit bionxt.com

BioNxt Solutions Inc. Common Share Purchase Warrants Regulatory Approvals Debentures Maturity Dates
BRIEF

published on 05/19/2026 at 09:10, 1 month 1 day ago

BioNxt Progresses in Semaglutide Oral Dissolvable Film Development

Pharmaceutical Development BioNxt Solutions GLP-1 Therapies Sublingual Drug Delivery Semaglutide ODF

Accesswire

Published on 06/20/2026 at 01:00, 1 day 2 hours ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day 3 hours ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 1 day 22 hours ago

Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 2 hours ago

American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 2 hours ago

Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting

View all ACCESSWIRE

EQS Group

Published on 06/20/2026 at 21:25, 5 hours 55 minutes ago

VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 21 hours 21 minutes ago

Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 7 hours ago

2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 1 day 7 hours ago

2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 1 day 8 hours ago

Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting

Les Echos

Published on 06/19/2026 at 19:33, 1 day 7 hours ago

Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 1 day 7 hours ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 7 hours ago

Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 1 day 7 hours ago

Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/19/2026 at 19:05, 1 day 8 hours ago

CP - Changement de gouvernance

View all LES ECHOS COMFI WIRE